• A new newsletter every four weeks that includes reviews of the latest clinical studies in neurology.
• Each article is doctor-written and comes complete with commentary and recommendations, a Take Home Pearl, or critical discussion points.
• Earn a maximum of 24 hours in Category 1 credit from American Academy of Neurology online or manually at no additional cost with your 12-issue subscription.
• Self-assessment quizzes to highlight key points and strengthen what you've learned.
• Free access to CME Central featuring online CME solutions, including: a personal credit tracking system, instant access to certificates, online access to the neurology database, and much more!

Educational Objectives: This activity is designed to provide neurologists and others interested in the diagnosis and treatment of diseases of the brain, spinal cord, peripheral nerve and muscle with a regular overview and analysis of the most current literature, as it pertains to strategies and advances in the diagnosis and treatment of conditions affecting the human central and peripheral nervous systems and skeletal muscle.

Accreditation statement: American Academy of Neurology is accredited by the ACCME to provide continuing medical education for physicians.

Designation statement: American Academy of Neurology designates this educational activity for a maximum of 24 AMA PRA Category 1 Credit(s) ™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Full Disclosure Policy Affecting CME Activities: As a provider accredited by the Accreditation Council for Continuing Medical Education (ACCME), The American Academy of Neurology must ensure balance, independence, objectivity, and scientific rigor in all its individually sponsored or jointly sponsored educational activities. All faculty participating in a sponsored activity are expected to disclose to the activity audience any significant financial interest or other relationship (1) with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services discussed in an educational presentation and (2) with any commercial supporters of the activity. (Significant financial interest or other relationship can include such things as grants or research support, employee, consultant, major stockholder, member of speakers¹ bureau, etc.) The intent of this disclosure is not to prevent a speaker with a significant financial or other relationship from making a presentation, but rather to provide listeners with information on which they can make their own judgments. It remains for the audience to determine whether the speaker¹s interests or relationships may influence the presentation with regard to exposition or conclusion.

Notice About Off-Label Use Presentations: The American Academy of Neurology activity entitled Practical Reviews Neurology may include presentations on drugs or devices, or uses of drugs or devices, which have not been approved by the Food and Drug Administration (FDA) or have been approved by the FDA for specific uses only. The FDA has stated that it is the responsibility of the physician to determine the FDA clearance status of each drug or device he or she wishes to use in clinical practice and make meaningful disclosure to the audience.